Peter Bisgaard

Peter Bisgaard is on these Sector & Stage Rankings

Peter Bisgaard's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Addition Therapeutics	Series ADec 2025$100M	$100M
Co-investors: Jayson Punwani (Abingworth), Jennifer Lee (Pivotal Life Sciences)
Engrail Therapeutics	Series BMar 2024$170M Series AAug 2021$32M Series AJun 2020$32M	$230M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Heath Lukatch (Red Tree Venture Capital), Jasper Bos (Forbion), Niall O’Donnell (RiverVest Venture Partners)
Oculis	Series CMay 2021$57M Series BJan 2019$16M	$190M
Co-investors: Rob Hopfner (Pivotal Life Sciences), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Eargo	Series EJul 2020$82M Series DMar 2019$52M Series COct 2017$45M	$220M
Co-investors: Josh Makower (New Enterprise Associates (NEA)), Pierre Lamond (Khosla Ventures), David Wu (Maveron), Dan Levitan (Maveron LLC), Juliet Tammenoms Bakker (Longitude Capital), Ben Capell (Salt VC), Farzad Nazem
OncXerna Therapeutics	Series BJun 2019$80M	$80M
Ceterix Orthopaedics	Series BMay 2014$18M	$18M
Co-investors: Charles Warden (Versant Ventures)
Otonomy	Series DApr 2014$49M Series CSep 2013$46M Series BAug 2010$39M Series BAug 2010$39M	$180M
Co-investors: Brian Dovey (Domain Associates), John McKearn (RiverVest Venture Partners), Niall O’Donnell (RiverVest Venture Partners), Heather Preston (Oxonian Ventures ), Jay Lichter (Madrona Venture Group), Bill Harrington (Osage University Partners (OUP)), Chau Khuong (Catalio Capital Management)
Nevro	Series CMar 2013$48M	$130M
Co-investors: Asish Xavier (Johnson & Johnson Innovation), Paul Klingenstein (Aberdare Ventures)

Peter Bisgaard's Experience

Peter Bisgaard's Education